Healthcare and Pharmaceuticals industry

Global Uveitis Treatment Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Uveitis refers to an autoimmune eye disease that causes inflammation in the uvea of the eye. Uveitis is considered to be one of the leading cause of blindness in the U.S. According to the Ocular Immunology and Uveitis Foundation in 2016, Uveitis is the third leading cause of blindness in the U.S. having affecting approximately 38 cases per 100,000 population. The three common types of uveitis are anterior uveitis (swelling of the uvea towards the front of the eye), intermediate uveitis (swelling in the middle of the eye), and posterior uveitis (swelling of the uvea towards the back of the eye). Panuveitis refers to a case in which all three areas of the eye are affected by inflammation. The most common type among the three is the anterior uveitis.
Market Dynamics
Major factors driving growth of the global uveitis treatment market include rising incidence of uveitis and complications associated with the disease. According to a survey published in research journal of JAMA Ophthalmology, non-infectious uveitis was reported in 121 cases per 100,000 adults and 29 per 100,000 children in 2016. Various other factors supporting the market growth include rising expenditure in research and development for new therapies to treat uveitis as well as speedy approvals from U.S. FDA for the drugs in pipeline to treat the condition. However, factors such as irreversible blindness in some cases due to side effects of medications and other such medical conditions can thus, hinder the market growth for global uveitis treatment. The side effects associated with corticosteroids include high blood pressure, kidney damage, skin disorders, and others.
Key features of the study:

This report provides in-depth analysis of uveitis treatment market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global uveitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans


Key companies covered as a part of this study include AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics


The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the uveitis treatment Market

Detailed Segmentation:

Global Uveitis Treatment Market, By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

Global Uveitis Treatment Market, By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

Global Uveitis Treatment Market, By Cause:

Infectious Uveitis
Non-Infectious Uveitis

Global Uveitis Treatment Market, By Geography:

North America

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

U.S.
Canada


Europe

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe


Asia Pacific

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific


Latin America

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

Brazil
Mexico
Rest of Latin America


Middle East

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

GCC
Israel
Rest of Middle East


Africa

By Treatment:

Corticosteroids
Immunosuppressants
Monoclonal Antibodies
Cycloplegic Agents
Antibiotics
Antifungals
Antivirals
Analgesics

By Disease Type:

Anterior Uveitis
Posterior Uveitis
Intermediate Uveitis
Panuveitis

By Cause:

Infectious Uveitis
Non-Infectious Uveitis

By Country:

South Africa
Central Africa
North Africa



Company Profiles

AbbVie, Inc.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Novartis AG
Eyegate Pharmaceuticals, Inc.
Santen Pharmaceuticals
Alimera Sciences
Regeneron Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.
Allergan Plc


 “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Treatment
? Market Snippet By Disease Type
? Market Snippet By Cause
? Market Snippet By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
? Market Trends
o Pipeline Analysis
o Novel Innovation in Uveitis Treatment
o Epidemiology
4. Global Uveitis Treatment Market, By Treatment, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Corticosteroids
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Immunosuppressant
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Monoclonal Antibodies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Cycloplegic Agents
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Antibiotics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Antivirals
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Antifungal
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Analgesics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
5. Global Uveitis Treatment Market, By Disease Type, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Anterior Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Posterior Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Intermediate Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Panuveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
6. Global Uveitis Treatment Market, By Cause, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Infectious Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
o Non- infectious Uveitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Mn)
7. Global Bone Graft and Substitutes Market, By Region, 2017 - 2025, (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2017 - 2025
o North America
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Europe
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Treatment, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Disease Type, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Cause, 2017 - 2025, (US$ Mn)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Mn)
? South Africa
? Central Africa
? North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
? Santen Pharmaceutical Co., Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Regeneron Pharmaceuticals, Inc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Allergan Plc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Valeant Pharmaceutical International, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Abbvie, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Alimera Sciences
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
?
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 35 market data tables and 30 figures on "Global Uveitis Treatment Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.